Patents
1. US Patent, 11640662, “Somatic mutation detection apparatus and method with reduced sequencing platform-specific error”. 2023. Granted.
2. Japan Patent, 7411079, “Somatic mutation detection apparatus and method with reduced sequencing platform-specific error”. 2023. Granted.
3. The Republic of Korea Patent, 10-2671298, “Apparatus and method for detecting somatic variant using machine learning model build by reflecting normal cell contamination level”. 2024. Granted.
4. The Republic of Korea Patent, 10-2691743, “Somatic mutation detection apparatus and method with reduced sequencing platform-specific error”. 2024. Granted.
5. The Republic of Korea Patent, 10-2700202, "코로나바이러스감염증-19의 치료에 사용하기 위한 SARS-CoV-2 번역 조절 저해 활성을 갖는 안티센스 올리고뉴클레오타이드". 2024. Granted.
6. The Republic of Korea Patent, 10-2690306, "SARS-CoV-2 증식억제효과를 보이는 TIS-L 표적 안티센스 올리고뉴클레오타이드". 2024. Granted.
7. India Patent, 547802, “Somatic mutation detection apparatus and method with reduced sequencing platform-specific error”. 2024. Granted.